Literature DB >> 15992466

Conservative management of sporadic unilateral acoustic neuromas.

David Flint1, Paul Fagan, Alessandro Panarese.   

Abstract

Our objective was to review retrospectively patients with a unilateral acoustic neuroma managed by observation. One hundred patients with tumours (<24 mm) were followed a median 25.5 months. Thirty-six acoustic neuromas grew with four growth patterns. No factors were associated with growth. Eighty percent of growing tumours grew in the first year. Eleven patients proceeded to surgery. Twenty-two patients were eligible for hearing preservation surgery; five of the 15 available for analysis subsequently lost eligibility. In conclusion, selected patients can be safely observed with serial imaging and follow up. Size increase in the first year may predict future growth. Delaying surgery until required by symptoms or tumour growth does not result in more morbidity for the patient. Some may lose the opportunity for hearing preservation surgery but operating on all would result in more sustaining a loss of hearing in the first few years after diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 15992466     DOI: 10.1258/0022215054273089

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  10 in total

1.  Expectant management of vestibular schwannoma: a retrospective multivariate analysis of tumor growth and outcome.

Authors:  Mark Hughes; Christopher Skilbeck; Shakeel Saeed; Robert Bradford
Journal:  Skull Base       Date:  2011-09

2.  Should initial surveillance of vestibular schwannoma be abandoned?

Authors:  Sarah Eljamel; Musheer Hussain; M Sam Eljamel
Journal:  Skull Base       Date:  2011-01

3.  Long-term natural history and patterns of sporadic vestibular schwannoma growth: A multi-institutional volumetric analysis of 952 patients.

Authors:  John P Marinelli; Zane Schnurman; Daniel E Killeen; Ashley M Nassiri; Jacob B Hunter; Katherine A Lees; Christine M Lohse; J Thomas Roland; John G Golfinos; Douglas Kondziolka; Michael J Link; Matthew L Carlson
Journal:  Neuro Oncol       Date:  2022-08-01       Impact factor: 13.029

4.  Clinical features of intracranial vestibular schwannomas.

Authors:  Xiang Huang; Jian Xu; Ming Xu; Liang-Fu Zhou; Rong Zhang; Liqin Lang; Qiwu Xu; Ping Zhong; Mingyu Chen; Ying Wang; Zhenyu Zhang
Journal:  Oncol Lett       Date:  2012-10-31       Impact factor: 2.967

5.  Predictors of future growth of sporadic vestibular schwannomas obtained by history and radiologic assessment of the tumor.

Authors:  Janneke C J M Artz; Ferdinand C A Timmer; Jef J S Mulder; Cor W R J Cremers; Kees Graamans
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

6.  EAONO position statement on Vestibular Schwannoma: Imaging Assessment Question: How should growth of Vestibular Schwannoma be defined?

Authors:  Romain Kania; Benjamin Vérillaud; Domitille Camous; Charlotte Hautefort; Thomas Somers; Jérôme Waterval; Sébastien Froelich; Philippe Herman
Journal:  J Int Adv Otol       Date:  2018-04       Impact factor: 1.017

Review 7.  Magnetic Resonance Imaging-Based Screening for Asymptomatic Brain Tumors: A Review.

Authors:  Alfred I Neugut; Paul Sackstein; Grace C Hillyer; Judith S Jacobson; Jeffrey Bruce; Andrew B Lassman; Philip A Stieg
Journal:  Oncologist       Date:  2018-10-10

8.  Management of growing vestibular schwannomas.

Authors:  Gian Gaetano Ferri; Antonio Pirodda; Alberto Rinaldi Ceroni; Antonio Fioravanti; Fabio Calbucci; Giovanni Carlo Modugno
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-08       Impact factor: 2.503

9.  Conservative treatment of vestibular schwannoma: growth and Penn Acoustic Neuroma Quality of Life scale in French language.

Authors:  P A Oddon; M Montava; F Salburgo; M Collin; C Vercasson; J P Lavieille
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-08       Impact factor: 2.124

10.  Vestibular Schwanomma: An Experience in a Developing World.

Authors:  Prakash Bahadur Thapa; Sudha Shahi; Rajiv Kumar Jha; Deependra Shrestha
Journal:  World J Oncol       Date:  2019-04-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.